ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

GDF15 expression in glioma is associated with malignant progression, immune microenvironment, and serves as a prognostic factor

Guo, Longbin; Chen, Yulei; Hu, Shushu; Gao, Lianxuan; Tang, Nan; Liu, Rongping; Qin, Yue; Ren, Chen*; Du, Shasha*南方医科大学
CNS Neuroscience & Therapeutics2022-1DOI: 10.1111/cns.13749
9被引7阅读
引用收藏
分享

摘要

Aims Growth differentiation factor 15 (GDF15) is involved in lots of crucial inflammatory and immune response. The clinical and immune features for GDF15 in glioma have not been specifically investigated so far. Methods Gene expression profiles obtained from public glioma datasets were used to explore the biological function of GDF15 and its impact on immune microenvironment. Interference with GDF15 in several glioma cell lines to verify its functions in vitro. Survival data were used for the survival analysis and establishment of a nomogram predictive model. Results GDF15 was up-regulated in various malignant phenotypes of glioma. Function analysis and in vitro experiments revealed that GDF15 was associated with malignant progression and NF-kappa B pathway. GDF15 was closely correlated to inflammatory response, infiltrating immune cells, and immune checkpoint molecules, especially in lower grade glioma (LGG). High expression level of GDF15 predicted poor survival in LGG, while the effect on glioblastoma (GBM) was not significant. A nomogram predictive model combining GDF15 and other prognostic factors was constructed and showed ideal predictive performance. Conclusions GDF15 could serve as an interesting prognostic biomarker for LGG. Regulating the expression of GDF15 may help solve the dilemma of immunotherapy in glioma.

学科与关键词

关键词
GDF15gliomabiomarkerImmuneprognosis
相关
加载中…
  • Prognostic Features of the Tumor Immune Microenvironment in Glioma and Their Clinical Applications: Analysis of Multiple Cohorts
    Zhang, Chunlong; Zhang, Yuxi; Tan, Guiyuan; Mi, Wanqi; Zhong, Xiaoling; Zhang, Yu; Zhao, Ziyan; Li, Feng*; Xu, Yanjun*; Zhang, Yunpeng*Frontiers in Immunology, 2022, 13: 853074.被引 1
  • Developing an Immune-Related Signature for Predicting Survival Rate and the Response to Immune Checkpoint Inhibitors in Patients With Glioma
    Zhang, Sibin; Xiao, Xu; Wang, Yu; Song, Tianjun; Li, Chenlong; Bao, Hongbo; Liu, Qing; Sun, Guiyin; Sun, Xiaoyang; Su, Tianqi; Fu, Tianjiao; Wang, Yujie; Liang, Peng*Frontiers in Genetics, 2022, 13: 899125.被引 2
  • EVA1B to Evaluate the Tumor Immune Microenvironment and Clinical Prognosis in Glioma
    Qu, Shanqiang*; Liu, Jin; Wang, Huafu*Frontiers in Immunology, 2021, 12: 648416.被引 15
查看全部 →

发表信息

论文状态
公开发表
期刊
CNS Neuroscience & Therapeutics
发表日期
2022-01
卷期
第 28 卷, 第 1 期
页码
158-171
DOI
10.1111/cns.13749
语言
ENGLISH
成果收录
SCIE
资助标注
Natural Science Foundation of Guangdong Province [2020A1515010186]; National Natural Science Foundation of China [81972970, 82172671]

作者

  • G

    Guo, Longbin (第一作者)

    southern med univ

  • C

    Chen, Yulei

    southern med univ

查看全部 9 位作者收起作者
  • H

    Hu, Shushu

    southern med univ

  • G

    Gao, Lianxuan

    southern med univ

  • T

    Tang, Nan

    southern med univ

  • L

    Liu, Rongping

    southern med univ

  • Q

    Qin, Yue

    southern med univ

  • R

    Ren, Chen (通讯)

    southern med univ

  • D

    Du, Shasha (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417